Are you Dr. Goldsmith?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Beth Israel Deaconess Med Ctr
330 Brookline Ave., Pathology
Boston, MA 02215Phone+1 617-667-2586
Summary
- Dr. Jeffrey Goldsmith, MD is a board certified pathologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Pennsylvania, and Pennsylvania. He is an Assistant Professor of Pathology at Beth Israel Deaconess Medical Center.
Education & Training
Wayne State University School of MedicineClass of 1996
Certifications & Licensure
MA State Medical License 2002 - 2026
PA State Medical License 1997 - 2002- PA State Medical License 1997 - 2002
American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- Current status and future directions in food protein-induced enterocolitis syndrome: An NIAID workshop report of the June 22, 2022, virtual meeting.Anna Nowak-Wegrzyn, Scott H Sicherer, Cem Akin, Sara Anvari, Lisa M Bartnikas
The Journal of Allergy and Clinical Immunology. 2025-02-01 - Cytomegalovirus Colitis in a Patient With Ulcerative Colitis With Loss of Corticosteroid Response Upon Upadacitinib Initiation.Jonathan A Salazar, Jeffrey D Goldsmith, Athos Bousvaros, Michaela Tracy
Gastroenterology & Hepatology. 2024-10-01 - Clinical characteristics and outcomes of pediatric patients with autoimmune gastritis.Maya Granot, Beate C Beinvogl, Michael Schvimer, Jeffrey D Goldsmith, Manar Matar
Journal of Pediatric Gastroenterology and Nutrition. 2024-09-01
Press Mentions
CAP Opens Updated Draft Guideline for Public CommentAugust 4th, 2021
Written Surveys Prove Best for Judging if Lab Practice Guidelines Are WorkingJune 28th, 2019- CAP Updates Validation of Immunohistochemical Assays Testing Guideline for Precise Results, Improved Patient CareFebruary 24th, 2024
